Balasa Dinverno & Foltz LLC Gilead Sciences, Inc. Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 9,426 shares of GILD stock, worth $885,572. This represents 0.04% of its overall portfolio holdings.

Number of Shares

9,426

Previous 6,118 54.07%

Holding current value

$885,572

Previous $378,000 53.7%

% of portfolio

0.04%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $196,958 - $224,977	3,308 Added 54.07%	9,426 $581,000
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $39,595 - $44,596	-686 Reduced 10.08%	6,118 $378,000
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $235,676 - $295,328	-4,069 Reduced 37.42%	6,804 $404,000
Q4 2021 Jan 26, 2022	BUY	$64.88 - $73.64 $171,348 - $194,483	2,641 Added 32.08%	10,873 $789,000
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $1,692 - $1,825	25 Added 0.3%	8,232 $575,000
Q2 2021 Jul 23, 2021	SELL	$63.47 - $69.35 $121,671 - $132,943	-1,917 Reduced 18.94%	8,207 $565,000
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $156,900 - $179,022	2,615 Added 34.82%	10,124 $654,000
Q4 2020 Jan 26, 2021	BUY	$56.65 - $64.55 $40,788 - $46,476	720 Added 10.61%	7,509 $437,000
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $626,402 - $787,592	-10,087 Reduced 59.77%	6,789 $429,000
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $292,904 - $340,116	4,049 Added 31.57%	16,876 $1.3 Million
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $191,835 - $245,713	3,063 Added 31.37%	12,827 $959,000
Q4 2019 Jan 22, 2020	SELL	$61.62 - $67.78 $65,810 - $72,389	-1,068 Reduced 9.86%	9,764 $634,000
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $7,563 - $8,349	-121 Reduced 1.1%	10,832 $687,000
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $167,543 - $187,881	2,708 Added 32.84%	10,953 $740,000
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $53,025 - $59,402	848 Added 11.46%	8,245 $536,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $464,462 - $606,088	-7,672 Reduced 50.91%	7,397 $463,000
Q3 2018 Oct 24, 2018	SELL	$71.28 - $78.92 $62,583 - $69,291	-878 Reduced 5.51%	15,069 $1.16 Million
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $317,522 - $370,377	-4,894 Reduced 23.48%	15,947 $1.13 Million
Q1 2018 Apr 23, 2018	SELL	$72.84 - $88.8 $72,985 - $88,977	-1,002 Reduced 4.59%	20,841 $1.57 Million
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $33,867 - $39,755	-476 Reduced 2.13%	21,843 $1.57 Million
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $1.61 Million - $1.91 Million	22,319	22,319 $1.81 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Gilead Sciences, Inc. Transaction History